Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel
Journal cover image

625 COVID-19 vaccination in patients with renal cancer or melanoma receiving immune checkpoint inhibitors

Publication ,  Conference
Hwang, J; Dzimitrowicz, H; Shah, R; Ashcraft, K; George, D; Salama, A; Zhang, T
Published in: Journal for ImmunoTherapy of Cancer
November 2021

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Journal for ImmunoTherapy of Cancer

DOI

EISSN

2051-1426

Publication Date

November 2021

Volume

9

Issue

Suppl 2

Start / End Page

A655 / A655

Publisher

BMJ

Related Subject Headings

  • 3211 Oncology and carcinogenesis
  • 3204 Immunology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Hwang, J., Dzimitrowicz, H., Shah, R., Ashcraft, K., George, D., Salama, A., & Zhang, T. (2021). 625 COVID-19 vaccination in patients with renal cancer or melanoma receiving immune checkpoint inhibitors. In Journal for ImmunoTherapy of Cancer (Vol. 9, pp. A655–A655). BMJ. https://doi.org/10.1136/jitc-2021-sitc2021.625
Hwang, Joyce, Hannah Dzimitrowicz, Riddhishkumar Shah, Kathleen Ashcraft, Daniel George, April Salama, and Tian Zhang. “625 COVID-19 vaccination in patients with renal cancer or melanoma receiving immune checkpoint inhibitors.” In Journal for ImmunoTherapy of Cancer, 9:A655–A655. BMJ, 2021. https://doi.org/10.1136/jitc-2021-sitc2021.625.
Hwang J, Dzimitrowicz H, Shah R, Ashcraft K, George D, Salama A, et al. 625 COVID-19 vaccination in patients with renal cancer or melanoma receiving immune checkpoint inhibitors. In: Journal for ImmunoTherapy of Cancer. BMJ; 2021. p. A655–A655.
Hwang, Joyce, et al. “625 COVID-19 vaccination in patients with renal cancer or melanoma receiving immune checkpoint inhibitors.” Journal for ImmunoTherapy of Cancer, vol. 9, no. Suppl 2, BMJ, 2021, pp. A655–A655. Crossref, doi:10.1136/jitc-2021-sitc2021.625.
Hwang J, Dzimitrowicz H, Shah R, Ashcraft K, George D, Salama A, Zhang T. 625 COVID-19 vaccination in patients with renal cancer or melanoma receiving immune checkpoint inhibitors. Journal for ImmunoTherapy of Cancer. BMJ; 2021. p. A655–A655.
Journal cover image

Published In

Journal for ImmunoTherapy of Cancer

DOI

EISSN

2051-1426

Publication Date

November 2021

Volume

9

Issue

Suppl 2

Start / End Page

A655 / A655

Publisher

BMJ

Related Subject Headings

  • 3211 Oncology and carcinogenesis
  • 3204 Immunology